Wednesday, October 23, 2024
spot_img

Alliance Witan PLC – Transaction In Own Shares

Alliance Witan PLC
LEI: 213800SZZD4E2IOZ9W55
  
TRANSACTION IN OWN SHARES
 
Alliance Witan PLC (“the Company”) announces that today the Company purchased 225,000 ordinary shares of 2.5p each at a price of 1,216.0p per share, to be held in Treasury.
 
Following the transaction, the Company’s issued share capital comprises 405,193,982 ordinary shares of which 3,952,000 ordinary shares are held in Treasury. Therefore, the total voting rights in the Company is 401,241,982 ordinary shares.
 
For reporting purposes under the FCA’s Disclosure Guidance and Transparency Rules the market should exclude any shares held in Treasury and should use the figure 401,241,982 when determining if they are required to notify their interest in, or a change to their interest in the Company.
 
Enquiries:
 
Juniper Partners Limited
Company Secretary
 
Telephone: 0131 378 0500
 
23 October 2024

Powered by SlickText.com

Hot this week

Weekly share repurchase program transaction details

October 23, 2024 SBM Offshore reports the transaction...

PayPoint plc : Director/PDMR Shareholding

23 October 2024 PayPoint plc ("the Company") ...

Transaction in Own Shares

Transaction in Own Shares 23 October, 2024 ...

Umicore – Transparency notifications by BlackRock, Inc. and by Bank of America Corp.

Transparency notifications by BlackRock, Inc. and by Bank of...

Daré Bioscience Selected to Receive $10 Million Award from ARPA-H’s Sprint for Women’s Health

DARE-HPV is a potential first-in-category treatment for human papillomavirus...

Topics

Weekly share repurchase program transaction details

October 23, 2024 SBM Offshore reports the transaction...

PayPoint plc : Director/PDMR Shareholding

23 October 2024 PayPoint plc ("the Company") ...

Transaction in Own Shares

Transaction in Own Shares 23 October, 2024 ...

Umicore – Transparency notifications by BlackRock, Inc. and by Bank of America Corp.

Transparency notifications by BlackRock, Inc. and by Bank of...

Daré Bioscience Selected to Receive $10 Million Award from ARPA-H’s Sprint for Women’s Health

DARE-HPV is a potential first-in-category treatment for human papillomavirus...

SYNERGIE : Q3 2024 REVENUES

Q3 2024 REVENUES In challenging market conditions, SYNERGIE...

2024 third quarter turnover: 131.1 million euros

2024 third quarter turnover: 131.1 million euros ...
spot_img

Related Articles

Popular Categories

spot_img